Enterome raised €16M in a funding round in Jun 2025. The company is based in Paris, France. Investors in the round: existing specialist investors, The Institute for Follicular Lymphoma Innovation (IFLI) , The Leukemia & Lymphoma Society Therapy Acceleration Program® (LLS TAP). Data as of 21 Sept 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
